However, in ccRCC the total number of non-synonymous mutations, neoantigens, frame shift mutations and degree of CD8+ T cell infiltration do not correlate with response to anti-PD-1 therapy4,5. The gene discussed is PDCD1; the disease is nonpapillary renal cell carcinoma.